In the role of CEO, Joe will manage MassBio’s federal affairs, state and municipal government relations, and will take the lead on initiatives to sustain Massachusetts’ economic competitiveness focusing on issues around infrastructure, workforce, and digital health. Prior to joining MassBio in September 2021, Joe served as the State Senator for the First Suffolk and Middlesex districts, representing his hometown of Winthrop; the Boston communities of East Boston, North End, Chinatown, Beacon Hill, Bay Village, and South End; the Cambridge neighborhoods of Cambridgeport, Riverside and MIT; and the City of Revere. While in the State Senate, Joe was the Chair of the Joint Committee on Transportation, Chair of the Senate’s Committee on Personnel and Administration, Chair of the Joint Committee on Housing, Vice Chair of Rules, and member of the Senate Ways and Means Committee, Senate Ethics Committee, Committee on Bonding, Capital Expenditures and State Assets, and the Committee on Financial Services. Before being elected to the state legislature in 2016, Joe practiced law specializing in criminal law in his private practice and as a public defender with Suffolk Lawyers for Justice. Since his early life, Boncore has been an active member in the Order Sons of Italy in America, he is currently the National Second Vice President. Boncore earned his bachelor’s degree in political science and government from Providence College in 2004 and received his juris doctorate from the Massachusetts School of Law. Joe resides in Winthrop with his wife Christine and twin sons John and Philip.

As President and COO, Kendalle leads the strategic direction, global expansion, and business operations of the organization ensuring that MassBio offers the greatest value to its members and that Massachusetts life sciences companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Kendalle first came to MassBio in 2008 as Director of Purchasing and Strategic Alliance. She was promoted to Vice President of Member Services and General Counsel in 2012, then promoted to the organization’s first-ever Chief Operating Officer in February 2019. Throughout her tenure at MassBio, Kendalle has played a critical role in the growth of MassBio’s membership supporting its expansion to become the largest life sciences trade association in the world with over 1,400 members. Kendalle has overseen the rebrand of a number of MassBio’s core programs and services, including the MassBio Edge, MassBio’s savings and rewards program, and its expansion into other New England states by building valuable partnerships with the supplier community and creating MassBio’s highly-rated Employee Rewards program. She also led the development of the MassBioHub, MassBio’s conference and business center, and the creation of MassBio’s 2025 State of Possible Report. In 2019, Kendalle commenced a multi-year digital health initiative to support the convergence of digital tech and the life sciences in Massachusetts. And in 2021, Kendalle was instrumental in the launch of MassBio’s Partnering Week, a new initiative to bring together established biopharma companies with early-stage startups and academic institutions. Kendalle has reached extraordinary heights in her growing career. She was named a 2019 Boston Business Journal 40 under 40 honoree which recognizes a leader’s impact on Massachusetts’ industries.

Pam Randhawa is CEO and Founder of Empiriko, a biotech company focused on developing R&D technologies for drug discovery and home-based point-of-care devices for personalized patient treatment. Pam has over 20 years of experience in the healthcare and life sciences industries with expertise ranging from policy, corporate strategy, product development, analytics and marketing for Fortune 500 companies, startups and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company using agriculture waste. Previously, Pam held several executive positions with major healthcare technology companies. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce for the Health Status of Ohioans for the State Health Plan to increase access and quality, reduce the cost of healthcare and improve public health in Ohio. Pam serves on the Board of Directors of the Massachusetts Life Sciences Center (MLSC), a state investment agency responsible for $1.6 billion fund to support life sciences innovation and create STEM related jobs in Massachusetts. She also serves on the Board of Directors of the Massachusetts Biotech Technology Council and a member of the World Economic Forum’s Global Future Council on Biotechnology. She chairs NSF/NIJ Industrial Advisory Board of Center for Advanced Research in Forensic Science and a member of the NIH review panel for SBIR/STTR Commercialization Readiness Pilot Program. Pam is a member of the Silent Spring Institute’s Leadership Council which studies the links between the environment and women’s health, with a focus on breast cancer. In addition, she serves on the Economic Development Planning Council for the State of MA. She serves as a judge for the Harvard Business School’s New Venture Competition and provides mentorship to startups and young professionals. Pam holds a bachelor’s degree in economics from the University of Rajasth